The goal of this observational study is to learn whether 68Ga-FAPI PET/CT may be used as a new effective methods for evaluating axillary lymph node efficacy after neoadjuvant treatment for breast cancer. The main question it aims to answer is:
Could 68Ga-FAPI PET/CT effectively evaluate axillary lymph node after neoadjuvant treatment for breast cancer? Participants will have a 68Ga-FAPI PET/CT test between last neoadjuvant therapy and surgery.
Female patients aged 18 and above
ECOG score 0-2 points
Pathological confirmation of malignant breast tumor
Clinical axillary lymph node positivity (cN+)
Distant metastasis
Unable to complete the proposed neoadjuvant therapy plan
Pregnancy
Kunwei Shen
Lead sponsor
Shanghai Jiao Tong University School of Medicine
Sponsor institution